FDA to review birth control implant Device after complaints
According to US regulators, this week, they would review a birth control implant device at a panel after multiple complaints. It was in 2002, when the implant, called Essure, was given green signal by the US Food and Drug Administration (FDA).
The small metal spring is placed in a woman's fallopian tubes in order that no egg is able to pass through. The FDA will have a follow up meeting on Thursday to discuss the safety of the device after numerous women have complained they faced debilitating side effects.
According to the FDA, "Over the past several years, the Agency met with patients and patient advocates to better understand patient issues and experiences after Essure placement. We will continue to work with these individuals as we continue our efforts to better understand their experiences with this device".
Pharmaceutics company Bayer, manufacturer of Essure, has admitted that there are side effects of the implant together with migration of the device or rash, pelvic pain. Many women complained that they have suffered from other unlisted side effects of the implant. A sufferer, Melanie Goshgarian, said that she experienced heavy bleeding and a 'metal taste in her mouth' after she got the implant.
According to her, she felt as if a shark was inside her body and her entire body started experiencing changes. She added that she was itchy and her arms and legs were tingling. The FDA said that there were 20,000 complaints from women who used Facebook and Twitter to share the experience.